SPOON: Sustained Program for Improving Nutrition - Colombia

December 14, 2017 updated by: Inter-American Development Bank
The primary goal of this study is to prevent undernutrition and obesity in peri-urban areas of Colombia. This study is designed to evaluate the impact of promoting adequate feeding practices and the use of SQ-LNS (Small Quantity Lipid-Based Nutrient Supplements) on the nutritional status of infants and young children. The study will be conducted in peri-urban areas of Pasto, Colombia in conjunction with Fundación Saldarriaga Concha and the Colombian Ministry of Health and Social Protection.

Study Overview

Detailed Description

SPOON Colombia is an innovative strategy to prevent undernutrition and obesity in children aged 0-24 months living in high-poverty areas of Colombia. The SPOON program aims to improve infant and young children feeding practices, including exclusive breastfeeding during a child's first six months and home-fortification with peanut-based SQ-LNS (small quantity lipid-based nutrient supplements) for children 6 to 24 months of age.

The SPOON intervention will randomly assign participants at the household level to one of three groups: a control group, Treatment Group 1, and Treatment Group 2. Participants in the control group will receive the standard services provided by their local health clinics in addition to a supply of micronutrient powder. The powder consists of vitamins and minerals that are added to the child's food to increase his or her consumption of micronutrients. Participants in Treatment Group 1 will receive group counseling and the SQ-LNS supplement instead of micronutrient powder. The group counseling program consists of various lessons for the children's caregivers about the importance of breastfeeding and providing high quality food with the SQ-LNS supplement. Those assigned to Treatment Group 2 will receive all the services that those in Treatment Group 1 receive in addition to individualized counseling, where messages about nutrition and breastfeeding will be reinforced through home visits.

Comparing the three treatment arms will identify the marginal impact of the SPOON program. For example, measuring the differences in outcomes between the participants in the control arm and in Treatment Group 1 will identify the impact of the Spoon program package, which includes SQ-LNS and group counseling, compared to current government-provided services. Measuring the differences between Treatment Group 1 and Treatment Group 2 will indicate the marginal impact of individualized counseling, and measuring the difference between the control arm and Treatment Group 2 will determine the combined impact of the SPOON program combined with individualized counseling.

Study Type

Interventional

Enrollment (Anticipated)

3000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 3 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants must live in the defined intervention areas

Exclusion Criteria:

  • Any chronic disease or malformation
  • Caretakers of the children plan on moving in the next 24 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standard Counseling and Micronutrients
Participants will receive standard services provided by the Ministry of Health, including powder micronutrients. Children receive 1 gram of powdered micronutrientes for 60 days between 6 and 12 months of age, and 60 daily packets per year from the time they are 1 year old until 5 years old.
Micronutrient powder is the current supplement provided by the Colombian Ministry of Health and Social Protection to children between 1 and 5 years of age.
Standard counseling refers to the counseling currently provided by health personnel to women and children in the selected intervention area of Colombia
Experimental: SPOON Group Counseling with SQ-LNS
Participants will receive the supplement SQ-LNS in addition to SPOON group counseling, which is a new form of social communication in which participants will learn relevant lessons in a group format. SQ-LNS consists of a 20g nutrient supplement package that is to be consumed daily between 6 and 24 months of age.
SPOON group counseling is an innovative behavior change strategy in which participants will learn information related to child health and nutrition in a group format.
Other Names:
  • Group
SQ-LNS is a peanut-based dietary supplement that has been shown to increase children's height and weight in several studies in Africa.
Other Names:
  • Small Quantity Lipid Nutrient Supplements
Experimental: Group, Interpersonal Counseling, SQ-LNS
Participants will receive the supplement SQ-LNS in addition to SPOON group and interpersonal counseling, which will consist of both participants learning relevant lessons in group format as well as in formats in which participants will work one-on-one with an instructor. SQ-LNS consists of a 20g nutrient supplement package that is to be consumed daily between 6 and 24 months of age.
SPOON group counseling is an innovative behavior change strategy in which participants will learn information related to child health and nutrition in a group format.
Other Names:
  • Group
SQ-LNS is a peanut-based dietary supplement that has been shown to increase children's height and weight in several studies in Africa.
Other Names:
  • Small Quantity Lipid Nutrient Supplements
SPOON interpersonal counseling is an innovative behavior change strategy in which participants will learn information via one-on-one sessions with the instructor.
Other Names:
  • SPOON Interpersonal Counseling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Height and Weight from Baseline to 8 months old
Time Frame: Measured when child is 6 months old at baseline and when child is 8 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 6 months old at baseline and when child is 8 months old
Change in Height and Weight from 8 months old to 10 months old
Time Frame: Measured when child is 8 months old and when child is 10 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 8 months old and when child is 10 months old
Change in Height and Weight from 10 months old to 12 months old
Time Frame: Measured when child is 10 months old and when child is 12 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 10 months old and when child is 12 months old
Change in Height and Weight from 12 months old to 14 months old
Time Frame: Measured when child is 12 months old and when child is 14 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 12 months old and when child is 14 months old
Change in Height and Weight from 14 months old to 16 months old
Time Frame: Measured when child is 14 months old and when child is 16 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 14 months old and when child is 16 months old
Change in Height and Weight from 16 months old to 18 months old
Time Frame: Measured when child is 16 months old and when child is 18 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 16 months old and when child is 18 months old
Change in Height and Weight from 18 months old to 20 months old
Time Frame: Measured when child is 18 months old and when child is 20 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 18 months old and when child is 20 months old
Change in Height and Weight from 20 months old to 22 months old
Time Frame: Measured when child is 20 months old and when child is 22 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 20 months old and when child is 22 months old
Change in Height and Weight from 22 months old to 24 months old
Time Frame: Measured when child is 22 months old and when child is 24 months old
Prevalence of stunting and being overweight, height for age z-score, body mass index z-score will be determined from measuring the height and weight of the subject
Measured when child is 22 months old and when child is 24 months old

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cephalic Circumference from Baseline
Time Frame: Measured when child is 6 months old and when child is 2 years old
An indicator often used as a proxy for child growth and development
Measured when child is 6 months old and when child is 2 years old
Change in Eating Habits from Baseline
Time Frame: Measured when child is 6 months old and when child is 2 years old
Include what kinds, quantity, and frequency of food was consumed
Measured when child is 6 months old and when child is 2 years old
Change in Health Status from Baseline
Time Frame: Measured when child is 6 months old and when child is 2 years old
General health status includes frequency and intensity of diarrhea
Measured when child is 6 months old and when child is 2 years old
Change in Measures of Caregiver Knowledge from Baseline
Time Frame: Measured when child is 6 months old and when child is 2 years old
Caregiver knowledge in nutrition, hygiene and exclusive breastfeeding will be measured
Measured when child is 6 months old and when child is 2 years old
Change in Prevalence of Anemia from Baseline
Time Frame: Measured when child is 6 months old and when child is 2 years old
The prevalence of anemia will be measured by reviewing hemoglobin and hematocrit levels
Measured when child is 6 months old and when child is 2 years old
Weight Gain Rate
Time Frame: Measured every 2 months when child is between 6 and 24 months old
Defined as rate of weight gain of the participating children
Measured every 2 months when child is between 6 and 24 months old

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2018

Primary Completion (Anticipated)

January 1, 2020

Study Completion (Anticipated)

January 1, 2020

Study Registration Dates

First Submitted

December 14, 2017

First Submitted That Met QC Criteria

December 14, 2017

First Posted (Actual)

December 20, 2017

Study Record Updates

Last Update Posted (Actual)

December 20, 2017

Last Update Submitted That Met QC Criteria

December 14, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Unidentified individual data will be shared among participating research institutions and made public 2 years after finalizing the study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Obesity

Clinical Trials on Micronutrients

3
Subscribe